Going In Reverse Is Faster Way Forward for Crescent Bio’s Cancer Immunotherapy

Crescent Biopharma is going public via a reverse merger with GlycoMimetics that will capitalize the combined company with $200 million. Crescent’s lead program is a bispecific antibody for cancer that replicates the properties of a Summit Therapeutics bispecific drug that recently trounced Merck’s blockbuster med Keytruda in a pivotal head-to-head study. The post Going In…

Read More

Florida Medical Device Maker Exactech Declares Bankruptcy

Exactech, a Florida device manufacturer that faces more than 2,000 state and federal lawsuits from patients who allege the company sold defective hip and knee implants, filed for bankruptcy protection Tuesday. The Gainesville-based company said in a statement it was restructuring and would be sold to an investor group of private equity and “alternative asset”…

Read More

MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes

In this episode, we’re joined by Dr. Tiffany Inglis, national medical director for women and children’s health at Carelon Health, a subsidiary of Elevance Health. Inglis discusses a paper Elevance Health Public Policy Institute recently published about doulas. The post MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes appeared first on MedCity News.

Read More

VBC, MA, FHIR and Modern Care

We know from everyday purchasing of goods and services that you have to combine what you’re getting with what you’re paying for that good or service. But how does this basic consumer supplier concept play out in US healthcare? The post VBC, MA, FHIR and Modern Care appeared first on MedCity News.

Read More